Timo Minssen

University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law

Professor, Jur. Dr., LL.M., M.I.C.L.

Karen Blixens Plads 16

Copenhagen, 2300

Denmark

http://jura.ku.dk/ciir/ansatte/?pure=da/persons/381631

SCHOLARLY PAPERS

24

DOWNLOADS
Rank 9,140

SSRN RANKINGS

Top 9,140

in Total Papers Downloads

4,212

CITATIONS

0

Scholarly Papers (24)

1.

The Rule of Reason under Article 82 EC after Sot Lelos Kai Sia

Number of pages: 29 Posted: 07 Jul 2009 Last Revised: 02 Sep 2015
Tu T. Nguyen, Timo Minssen and Xavier Groussot
Faculty of Law, Lund University, University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Lund University - Faculty of Law
Downloads 528 (38,745)

Abstract:

rule of reason, refusal to supply, parallel trade, pharmaceutical sector, Article 82 EC

2.

Res Judicata in the ECJ Case Law: Balancing Legal Certainty with Legality?

European Constitutional Law Review, Issue 3, pp. 385-417, 2007
Number of pages: 33 Posted: 06 Oct 2009 Last Revised: 02 Sep 2015
Xavier Groussot and Timo Minssen
Lund University - Faculty of Law and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 362 (35,301)

Abstract:

Res Judicata, European Court of Justice, Legal Certainty, Legality, Revision of Decisions, State Liability, Acte Clair; Kühne & Heitz, Köbler

3.

US Patent Eligibility in the Wake of Bilski v. Kappos: 'Business as Usual' in an Age of New Technologies?

Biotechnology Law Report, Vol. 30, Nr. 1, 2011, pp. 3-56, including a sequel at pp. 57-58.
Number of pages: 77 Posted: 26 Sep 2010 Last Revised: 01 Nov 2015
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Lund University Faculty of Law
Downloads 320 (75,584)

Abstract:

4.

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

Personalized Medicine, Vol. 11, No. 5, Pages 497-508
Number of pages: 16 Posted: 18 Jan 2014 Last Revised: 31 Dec 2014
Timo Minssen and Jens Schovsbo
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and University of Copenhagen Centre for Information and Innovation Law
Downloads 235 (80,773)

Abstract:

biobanks, law & ethics, intellectual property, informed consent, personalized medicine, open innovation, translational medicine

5.

Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were 'Obvious to Try' Still Might Be Non-Obvious – Part I

Chicago-Kent Journal of Intellectual Property, Vol. 9, Spring 2010
Number of pages: 72 Posted: 27 Sep 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 203 (115,067)

Abstract:

DNA-related inventions, patentability, inventive step, non-obviousness, obvious to try, biopharmaceutical industry, US, Europe

6.

The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

Published in Nordic Intellectual Property Law Review (NIR), Nr. 5, pp. 493-503 (2015).
Number of pages: 10 Posted: 13 Mar 2015 Last Revised: 25 Feb 2016
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and University of Copenhagen - Faculty of Law - Centre for Information and Innovation Law (CIIR)
Downloads 170 (46,780)

Abstract:

biotech, patents, Europe, stem cells, innovation policy

7.

The Impact of Broccoli II & Tomato II on European Patents in Conventional Breeding, GMO's and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?

Biotechnology Law Report, Vol. 34, No. 3 (2015), pp. 81-98
Number of pages: 24 Posted: 19 May 2015 Last Revised: 30 Jul 2017
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and University of Copenhagen - Faculty of Law - Centre for Information and Innovation Law (CIIR)
Downloads 169 (52,894)

Abstract:

Biotechnology, Patents, Plant Science, European Patent Office, GMOs, Synthetic Biology, Conventional breeding methods, essentially biological processes, agricultural industry, CRISPR, unitary patent

8.

Standardization, IPRs and Open Innovation in Synthetic Biology

Contribution to article compilation "Innovation, Competition, Collaboration" based on 2013 conference at Bucerius Law School, Hamburg, Germany
Number of pages: 20 Posted: 16 Feb 2014 Last Revised: 02 Sep 2015
Timo Minssen and Jakob Wested
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Centre for Information and Innovation Law
Downloads 134 (127,814)

Abstract:

standardization, open innovation, synthetic biology, intellectual property rights

9.

A Review of 'Patents and Technological Progress in a Globalized World - Liber Amicorum Joseph Straus'

The IP Law Book Review, Vol. 2, Issue 2, January 2012
Number of pages: 12 Posted: 01 Sep 2011 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 129 (169,774)

Abstract:

Patents, Pharmaceuticals, Biotechnology, IPR

10.

Restoring the Balance: The Patentability of DNA-Related Technology in the US and Europe

Number of pages: 10 Posted: 07 Oct 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 127 (172,685)

Abstract:

patent law, private law, comparative law, intellectual property law, patents, innovation system, biotechnology, DNA, proteins

11.

Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

Forthcoming in European Competition Law Review (E.C.L.R.). Issue 4, pp. 151-155 (Sweet & Maxwell 2014).
Number of pages: 6 Posted: 17 Feb 2014 Last Revised: 19 Feb 2014
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 74 (217,270)

Abstract:

Pharmaceutical law, Health law, Competition law, Innovation

12.

The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO & UK Case Law: A Plausible Approach or a Mere 'Hunting License'?

E.I.P.R. , Vol 34, Nr. 10, S. 689-703 (2012)
Number of pages: 23 Posted: 11 Sep 2014
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Independent
Downloads 56 (173,668)

Abstract:

13.

The US Examination of Nonobviousness after KSR vs. Teleflex with Special Emphasis on DNA-Related Inventions

IIC, Vol. 39, No. 8, pp. 886-916, 2008
Number of pages: 32 Posted: 13 Dec 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 44 (324,647)

Abstract:

KSR v. Telefex, Ex parte Kubin, nonobviousness, DNA-related inventions

14.

The 'Opt Out' and 'Opt-In' Provisions in the Unified Patent Court Agreement -- Impact and Strategies for European Patent Portfolios

Nordic Intellectual Property Law Review (NIR), Issue 4, pp 340-357 (2014)., University of Copenhagen Faculty of Law Research Paper No. 2015-3
Number of pages: 18 Posted: 22 Apr 2015 Last Revised: 08 Jul 2016
Timo Minssen and Bjorn Lundqvist
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Stockholm University - Faculty of Law
Downloads 35 (221,727)

Abstract:

Unitary patent, IPR, strategies, patent portfolios

15.

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Number of pages: 9 Posted: 28 Sep 2017
Jakob Wested and Timo Minssen
Centre for Information and Innovation Law and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 0 (499,008)

Abstract:

TRIPS, Life Science, Patents, Compulsory Licensing, Access to Medicine, NATCO

16.

Cutting Edges and Weaving Threads in the Gene Editing (Я)Evolution: Reconciling Scientific Progress with Legal, Ethical, & Social Concerns

Posted: 14 Sep 2017
University of Copenhagen - Faculty of Law - Centre for Information and Innovation Law (CIIR), University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law, University of Copenhagen - Department of Media, Cognition and Communication, University of Copenhagen - Department of Media, Cognition and Communication, Niels Bohr Institute, University of Copenhagen and University of Copenhagen - Centre for Synthetic Biology

Abstract:

Gene editing; Gene Drive; CRISPR/Cas9; Patents; Regulation; Interdisciplinary perspectives; Ethical and social concerns; law and technology; ELSI

17.

TRIPS and the Life Sciences - Perspectives on Limitations to Patentability

University of Copenhagen Faculty of Law Research Paper No. 2017-37
Number of pages: 9 Posted: 16 Jun 2017 Last Revised: 08 Jul 2017
Jakob Wested and Timo Minssen
Centre for Information and Innovation Law and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 0 (426,368)

Abstract:

TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology

18.

Patenting Bioprinting-Technologies in the US and Europe – The 5th Element in the 3rd Dimension

2017, “Patenting Bioprinting Technologies in the US and Europe– The 5th element in the 3rd dimension", Working Paper, Chapter 7 in: RM Ballardini, M Norrgård & J Partanen (red), 3D printing, Intellectual Property and Innovation – Insights from Law and Technology. Wolters Kluwer, Forthcoming,
Number of pages: 27 Posted: 08 Apr 2017 Last Revised: 18 Apr 2017
Timo Minssen and Marc Mimler
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM)
Downloads 0 (142,250)

Abstract:

19.

Six Recommendations on 'Synthetic Biology & Intellectual Property Rights'

Posted: 27 Feb 2016
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law, European Patent Office and University of Leuven

Abstract:

20.

Patenting Human Genes in Europe - And How It Compares to the US and Australia

Research Handbook on Intellectual Property and the Life Sciences (eds. Herbert Zech & Duncan Matthews), Chapter 1.5, Edward Elgar, 2016
Number of pages: 13 Posted: 27 Feb 2016 Last Revised: 08 Jul 2017
Timo Minssen
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law
Downloads 0 (210,183)

Abstract:

patents, DNA, Europe, Genes

21.

Enforcing Patents in the Era of 3D Printing

Journal of Intellectual Property Law & Practice, Vol. 10, No. 11:850-866 (2015)
Posted: 06 Dec 2015
University of Helsinki - IPR University Center, University of Helsinki and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law

Abstract:

3D printing, patents, IPR, enforcement

22.

A ‘Ray of Hope’ for European Stem Cell Patents or ‘Out of the Smog into the Fog’?: An Analysis of Recent European Case Law and How It Compares to the US

IIC - International Review of Intellectual Property and Competition Law, 47(2), 138-177, Marh 2016, DOI: 10.1007/s40319-016-0449-x
Posted: 27 Nov 2015 Last Revised: 07 Mar 2016
Ana Nordberg and Timo Minssen
University of Copenhagen - Faculty of Law - Centre for Information and Innovation Law (CIIR) and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law

Abstract:

Stem cell patents, EU, US, Biotechnology Directive, technical expertise, general courts

23.

Life after Myriad: The Uncertain Future of Patenting Biomedical Innovation & Personalized Medicine in an International Context

Intellectual Property Quarterly, Vol. 2015, Nr. 3, 08.2015, s. 189-241.
Posted: 21 Jun 2015 Last Revised: 05 Dec 2015
Robert M. Schwartz and Timo Minssen
Lund University Faculty of Law and University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law

Abstract:

Biotechnology, US, Europe, Australia, Comparative Law, DNA, Myriad, patent-eligibility, personalized medicine, genetic diagnostics, USPTO 2014 Guidelines, methods, innovation, Unified Patent Court

24.

Standing on Shaky Ground - US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO: Part I

Queen Mary Journal of Intellectual Property Law, Vol. 1, No. 3, 2011
Posted: 29 Sep 2011 Last Revised: 17 Dec 2015
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Information & Innovation Law - Faculty of Law and Independent

Abstract: